Filing Details
- Accession Number:
- 0001104659-16-139260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-12 12:49:37
- Reporting Period:
- 2016-08-10
- Filing Date:
- 2016-08-12
- Accepted Time:
- 2016-08-12 12:49:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1638287 | Gemphire Therapeutics Inc. | GEMP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296853 | S Jeffrey Mathiesen | 43334 Seven Mile Road Suite 1000 Northville MI 48167 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-10 | 3,927 | $6.71 | 3,927 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2016-08-10 | 4,000 | $10.00 | 7,927 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 8% Convertible Subordinated Promissory Note | Disposition | 2016-08-10 | 0 | $0.00 | 3,927 | $6.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- The note was issued in the original principal amount of $25,000. The outstanding principal and $1,337 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.